Eli Lilly launches digital health platform LillyDirect for obesity, migraine, and diabetes care
Eli Lilly and Company, a renowned pharmaceutical entity, has unveiled LillyDirect, an advanced digital healthcare platform primarily designed to aid patients in the United States with obesity, migraine, and diabetes management. The official announcement, made on January 4, 2024, marks a significant stride in the field of digital healthcare. LillyDirect emerges as a multifaceted tool,...Read MoreFasting regimen proves effective against obesity-induced cognitive decline
Researchers have recently explored the beneficial effects of intermittent fasting (IF) on neuroinflammation and cognitive decline in a study published in Nutrients. They focused on mice subjected to a high-fat diet (HFD) and examined the impacts of IF on brain health, particularly in the context of diabetic encephalopathy. Obesity and type 2 diabetes (T2D) are known for their adverse...Read Moreby Nicholas FeenieJanuary 8, 2024 Childhood Obesity, Exercise, Obesity and Population Health0 comments
Study confirms light exercise effectively counters childhood obesity
Childhood obesity, a growing concern worldwide, might have a surprisingly straightforward solution: light exercise. Recent research led by an international team of scientists from the Universities of Exeter, Eastern Finland, Bristol, and Colorado, underscores the profound impact of light physical activity in combating the rise of obesity in children. Drawing from the University of...Read Moreby Nicholas FeenieJanuary 5, 2024 Obesity and Population Health, Obesity Policy, Obesogenic Environment0 comments